| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.30e-10 | 26 | 25 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium ion binding | 1.90e-09 | 14 | 25 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | sodium channel activity | 5.02e-09 | 52 | 25 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.80e-08 | 26 | 25 | 4 | GO:0031420 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 3.65e-08 | 627 | 25 | 9 | GO:0022890 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 5.59e-08 | 171 | 25 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 5.97e-08 | 664 | 25 | 9 | GO:0008324 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.22e-08 | 465 | 25 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.85e-07 | 758 | 25 | 9 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 2.71e-07 | 793 | 25 | 9 | GO:0015075 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.17e-06 | 17 | 25 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.31e-06 | 343 | 25 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 7.35e-06 | 1180 | 25 | 9 | GO:0022857 | |
| GeneOntologyMolecularFunction | transporter activity | 1.50e-05 | 1289 | 25 | 9 | GO:0005215 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.74e-05 | 459 | 25 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | channel activity | 3.71e-05 | 525 | 25 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 3.75e-05 | 526 | 25 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 7.27e-05 | 182 | 25 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 7.59e-05 | 184 | 25 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | gated channel activity | 7.37e-04 | 334 | 25 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.88e-03 | 230 | 25 | 3 | GO:0005516 | |
| GeneOntologyMolecularFunction | amide binding | 5.99e-03 | 299 | 25 | 3 | GO:0033218 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 6.10e-03 | 301 | 25 | 3 | GO:0022853 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 7.18e-03 | 102 | 25 | 2 | GO:0001540 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 8.32e-03 | 337 | 25 | 3 | GO:0001664 | |
| GeneOntologyMolecularFunction | hormone activity | 1.23e-02 | 135 | 25 | 2 | GO:0005179 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 9.52e-10 | 36 | 27 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 6.04e-09 | 112 | 27 | 6 | GO:0019226 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 9.63e-09 | 121 | 27 | 6 | GO:0051899 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.60e-08 | 62 | 27 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.73e-08 | 63 | 27 | 5 | GO:0019228 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 8.16e-08 | 32 | 27 | 4 | GO:0048266 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 8.92e-08 | 87 | 27 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.25e-07 | 93 | 27 | 5 | GO:0086003 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 2.43e-07 | 208 | 27 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | response to pain | 5.58e-07 | 51 | 27 | 4 | GO:0048265 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 5.92e-07 | 127 | 27 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | behavior | 1.17e-06 | 891 | 27 | 9 | GO:0007610 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.24e-06 | 275 | 27 | 6 | GO:0006814 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.49e-06 | 153 | 27 | 5 | GO:0030048 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 1.55e-06 | 922 | 27 | 9 | GO:0098662 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell differentiation | 1.61e-06 | 18 | 27 | 3 | GO:0021702 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 1.85e-06 | 942 | 27 | 9 | GO:0098655 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer formation | 2.25e-06 | 20 | 27 | 3 | GO:0021694 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 2.29e-06 | 167 | 27 | 5 | GO:0060048 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 3.48e-06 | 1017 | 27 | 9 | GO:0098660 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer morphogenesis | 4.51e-06 | 25 | 27 | 3 | GO:0021692 | |
| GeneOntologyBiologicalProcess | action potential | 5.67e-06 | 201 | 27 | 5 | GO:0001508 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 7.38e-06 | 1115 | 27 | 9 | GO:0034220 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 8.23e-06 | 217 | 27 | 5 | GO:0006941 | |
| GeneOntologyBiologicalProcess | cell differentiation in hindbrain | 9.67e-06 | 32 | 27 | 3 | GO:0021533 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 9.96e-06 | 1157 | 27 | 9 | GO:0006812 | |
| GeneOntologyBiologicalProcess | cerebellar cortex formation | 1.17e-05 | 34 | 27 | 3 | GO:0021697 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer development | 1.77e-05 | 39 | 27 | 3 | GO:0021680 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 2.09e-05 | 126 | 27 | 4 | GO:0033555 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 2.38e-05 | 43 | 27 | 3 | GO:0062149 | |
| GeneOntologyBiologicalProcess | metal ion transport | 2.89e-05 | 1000 | 27 | 8 | GO:0030001 | |
| GeneOntologyBiologicalProcess | detection of stimulus | 3.01e-05 | 722 | 27 | 7 | GO:0051606 | |
| GeneOntologyBiologicalProcess | cerebellar cortex morphogenesis | 3.33e-05 | 48 | 27 | 3 | GO:0021696 | |
| GeneOntologyBiologicalProcess | heart contraction | 3.79e-05 | 298 | 27 | 5 | GO:0060047 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | 3.93e-05 | 1374 | 27 | 9 | GO:0006811 | |
| GeneOntologyBiologicalProcess | heart process | 4.50e-05 | 309 | 27 | 5 | GO:0003015 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 5.58e-05 | 57 | 27 | 3 | GO:0050974 | |
| GeneOntologyBiologicalProcess | cerebellum morphogenesis | 6.51e-05 | 60 | 27 | 3 | GO:0021587 | |
| GeneOntologyBiologicalProcess | walking behavior | 6.51e-05 | 60 | 27 | 3 | GO:0090659 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 7.03e-05 | 559 | 27 | 6 | GO:0042391 | |
| GeneOntologyBiologicalProcess | hindbrain morphogenesis | 7.90e-05 | 64 | 27 | 3 | GO:0021575 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 8.78e-05 | 582 | 27 | 6 | GO:0050906 | |
| GeneOntologyBiologicalProcess | cerebellar cortex development | 1.08e-04 | 71 | 27 | 3 | GO:0021695 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 1.27e-04 | 75 | 27 | 3 | GO:0050982 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 1.32e-04 | 912 | 27 | 7 | GO:0030029 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.52e-04 | 400 | 27 | 5 | GO:0006936 | |
| GeneOntologyBiologicalProcess | blood circulation | 1.58e-04 | 648 | 27 | 6 | GO:0008015 | |
| GeneOntologyBiologicalProcess | cellular response to antibiotic | 1.96e-04 | 16 | 27 | 2 | GO:0071236 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 2.46e-04 | 238 | 27 | 4 | GO:0050954 | |
| GeneOntologyBiologicalProcess | circulatory system process | 3.08e-04 | 733 | 27 | 6 | GO:0003013 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 3.43e-04 | 105 | 27 | 3 | GO:0019233 | |
| GeneOntologyBiologicalProcess | sensory perception | 3.56e-04 | 1072 | 27 | 7 | GO:0007600 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 4.81e-04 | 284 | 27 | 4 | GO:0007626 | |
| GeneOntologyBiologicalProcess | response to lead ion | 4.86e-04 | 25 | 27 | 2 | GO:0010288 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus involved in sensory perception of pain | 5.26e-04 | 26 | 27 | 2 | GO:0050965 | |
| GeneOntologyBiologicalProcess | positive regulation of monooxygenase activity | 5.68e-04 | 27 | 27 | 2 | GO:0032770 | |
| GeneOntologyBiologicalProcess | muscle system process | 6.41e-04 | 547 | 27 | 5 | GO:0003012 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus involved in sensory perception | 7.02e-04 | 30 | 27 | 2 | GO:0050961 | |
| GeneOntologyBiologicalProcess | cerebellum development | 7.78e-04 | 139 | 27 | 3 | GO:0021549 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 7.99e-04 | 32 | 27 | 2 | GO:0099505 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus | 8.50e-04 | 33 | 27 | 2 | GO:0016048 | |
| GeneOntologyBiologicalProcess | metencephalon development | 1.03e-03 | 153 | 27 | 3 | GO:0022037 | |
| GeneOntologyBiologicalProcess | sensory perception of temperature stimulus | 1.13e-03 | 38 | 27 | 2 | GO:0050951 | |
| GeneOntologyBiologicalProcess | negative regulation of stress fiber assembly | 1.19e-03 | 39 | 27 | 2 | GO:0051497 | |
| GeneOntologyBiologicalProcess | proton transmembrane transport | 1.39e-03 | 170 | 27 | 3 | GO:1902600 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 1.46e-03 | 173 | 27 | 3 | GO:0009581 | |
| GeneOntologyBiologicalProcess | regulation of monooxygenase activity | 1.51e-03 | 44 | 27 | 2 | GO:0032768 | |
| GeneOntologyBiologicalProcess | response to antibiotic | 1.51e-03 | 44 | 27 | 2 | GO:0046677 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 1.51e-03 | 175 | 27 | 3 | GO:0009582 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament bundle assembly | 1.58e-03 | 45 | 27 | 2 | GO:0032232 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 1.65e-03 | 46 | 27 | 2 | GO:0051353 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | 1.70e-03 | 1395 | 27 | 7 | GO:0007186 | |
| GeneOntologyBiologicalProcess | adult walking behavior | 1.94e-03 | 50 | 27 | 2 | GO:0007628 | |
| GeneOntologyBiologicalProcess | determination of adult lifespan | 2.26e-03 | 54 | 27 | 2 | GO:0008340 | |
| GeneOntologyBiologicalProcess | hindbrain development | 2.47e-03 | 208 | 27 | 3 | GO:0030902 | |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | 2.79e-03 | 217 | 27 | 3 | GO:0021953 | |
| GeneOntologyBiologicalProcess | neuromuscular process | 3.09e-03 | 225 | 27 | 3 | GO:0050905 | |
| GeneOntologyBiologicalProcess | response to cadmium ion | 3.56e-03 | 68 | 27 | 2 | GO:0046686 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 9.79e-12 | 17 | 25 | 5 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.86e-10 | 29 | 25 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | 2.80e-07 | 235 | 25 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 1.92e-06 | 523 | 25 | 7 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 2.68e-06 | 550 | 25 | 7 | GO:1990351 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 4.45e-06 | 378 | 25 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 2.73e-05 | 785 | 25 | 7 | GO:0098797 | |
| GeneOntologyCellularComponent | membrane protein complex | 3.47e-05 | 1498 | 25 | 9 | GO:0098796 | |
| GeneOntologyCellularComponent | axon | 6.11e-05 | 891 | 25 | 7 | GO:0030424 | |
| GeneOntologyCellularComponent | intercalated disc | 7.19e-05 | 68 | 25 | 3 | GO:0014704 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.88e-04 | 94 | 25 | 3 | GO:0044291 | |
| GeneOntologyCellularComponent | node of Ranvier | 2.57e-04 | 20 | 25 | 2 | GO:0033268 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.06e-04 | 277 | 25 | 4 | GO:0042734 | |
| GeneOntologyCellularComponent | axon initial segment | 5.47e-04 | 29 | 25 | 2 | GO:0043194 | |
| GeneOntologyCellularComponent | cell body | 6.49e-04 | 929 | 25 | 6 | GO:0044297 | |
| GeneOntologyCellularComponent | neuronal cell body | 2.74e-03 | 835 | 25 | 5 | GO:0043025 | |
| GeneOntologyCellularComponent | presynapse | 3.54e-03 | 886 | 25 | 5 | GO:0098793 | |
| GeneOntologyCellularComponent | T-tubule | 4.00e-03 | 79 | 25 | 2 | GO:0030315 | |
| GeneOntologyCellularComponent | synaptic membrane | 4.75e-03 | 583 | 25 | 4 | GO:0097060 | |
| GeneOntologyCellularComponent | main axon | 5.05e-03 | 89 | 25 | 2 | GO:0044304 | |
| HumanPheno | Progressive gait ataxia | 3.84e-09 | 30 | 12 | 5 | HP:0007240 | |
| HumanPheno | Progressive ataxia | 3.84e-09 | 30 | 12 | 5 | HP:0001329 | |
| HumanPheno | Facial tics | 2.38e-08 | 15 | 12 | 4 | HP:0011468 | |
| HumanPheno | Complex febrile seizure | 3.17e-08 | 16 | 12 | 4 | HP:0011172 | |
| HumanPheno | Abnormal autonomic nervous system physiology | 2.01e-07 | 130 | 12 | 6 | HP:0012332 | |
| HumanPheno | Limited knee extension | 3.01e-07 | 27 | 12 | 4 | HP:0003066 | |
| HumanPheno | Status epilepticus with prominent motor symptoms | 4.07e-07 | 29 | 12 | 4 | HP:0032658 | |
| HumanPheno | Photosensitive myoclonic seizure | 5.56e-07 | 8 | 12 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 5.56e-07 | 8 | 12 | 3 | HP:0200048 | |
| HumanPheno | Clonic seizure | 6.52e-07 | 81 | 12 | 5 | HP:0020221 | |
| HumanPheno | Generalized clonic seizure | 7.89e-07 | 34 | 12 | 4 | HP:0011169 | |
| HumanPheno | Limitation of knee mobility | 8.89e-07 | 35 | 12 | 4 | HP:0010501 | |
| HumanPheno | Limitation of neck motion | 9.99e-07 | 36 | 12 | 4 | HP:0005986 | |
| HumanPheno | Disturbance of facial expression | 9.99e-07 | 36 | 12 | 4 | HP:0005324 | |
| HumanPheno | Abnormal neck physiology | 9.99e-07 | 36 | 12 | 4 | HP:0025669 | |
| HumanPheno | Limited neck range of motion | 1.63e-06 | 11 | 12 | 3 | HP:0000466 | |
| HumanPheno | Epilepsia partialis continua | 2.17e-06 | 12 | 12 | 3 | HP:0012847 | |
| HumanPheno | Focal automatism seizure | 2.17e-06 | 12 | 12 | 3 | HP:0032898 | |
| HumanPheno | Atypical absence seizure | 2.73e-06 | 46 | 12 | 4 | HP:0007270 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 2.82e-06 | 13 | 12 | 3 | HP:0007058 | |
| HumanPheno | Status epilepticus | 3.16e-06 | 207 | 12 | 6 | HP:0002133 | |
| HumanPheno | Rigidity | 3.83e-06 | 214 | 12 | 6 | HP:0002063 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 4.47e-06 | 15 | 12 | 3 | HP:0007207 | |
| HumanPheno | Dysgenesis of the hippocampus | 5.50e-06 | 16 | 12 | 3 | HP:0025101 | |
| HumanPheno | Focal impaired awareness seizure | 5.90e-06 | 126 | 12 | 5 | HP:0002384 | |
| HumanPheno | Atypical absence status epilepticus | 6.67e-06 | 17 | 12 | 3 | HP:0011151 | |
| HumanPheno | Focal motor status epilepticus | 6.67e-06 | 17 | 12 | 3 | HP:0032663 | |
| HumanPheno | Focal motor seizure | 7.14e-06 | 131 | 12 | 5 | HP:0011153 | |
| HumanPheno | Visually-induced seizure | 7.99e-06 | 18 | 12 | 3 | HP:0020216 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 7.99e-06 | 18 | 12 | 3 | HP:0032860 | |
| HumanPheno | Tonic seizure | 9.90e-06 | 140 | 12 | 5 | HP:0032792 | |
| HumanPheno | Generalized tonic seizure | 1.04e-05 | 64 | 12 | 4 | HP:0010818 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 1.11e-05 | 20 | 12 | 3 | HP:0032671 | |
| HumanPheno | Infection-related seizure | 1.18e-05 | 145 | 12 | 5 | HP:0032892 | |
| HumanPheno | Seizure precipitated by febrile infection | 1.18e-05 | 145 | 12 | 5 | HP:0032894 | |
| HumanPheno | Febrile seizure (within the age range of 3 months to 6 years) | 1.18e-05 | 145 | 12 | 5 | HP:0002373 | |
| HumanPheno | Talipes valgus | 1.30e-05 | 21 | 12 | 3 | HP:0004684 | |
| HumanPheno | Generalized myoclonic seizure | 1.30e-05 | 148 | 12 | 5 | HP:0002123 | |
| HumanPheno | Impulsivity | 1.34e-05 | 149 | 12 | 5 | HP:0100710 | |
| HumanPheno | EEG with generalized epileptiform discharges | 1.48e-05 | 270 | 12 | 6 | HP:0011198 | |
| HumanPheno | Reflex seizure | 1.50e-05 | 22 | 12 | 3 | HP:0020207 | |
| HumanPheno | Tibial torsion | 1.72e-05 | 23 | 12 | 3 | HP:0100694 | |
| HumanPheno | Developmental regression | 1.85e-05 | 440 | 12 | 7 | HP:0002376 | |
| HumanPheno | Focal hemiclonic seizure | 2.23e-05 | 25 | 12 | 3 | HP:0006813 | |
| HumanPheno | Simple febrile seizure | 2.83e-05 | 27 | 12 | 3 | HP:0011171 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 2.83e-05 | 27 | 12 | 3 | HP:0031475 | |
| HumanPheno | Alien limb phenomenon | 3.04e-05 | 4 | 12 | 2 | HP:0032506 | |
| HumanPheno | Focal manual automatism seizure | 3.04e-05 | 4 | 12 | 2 | HP:0032900 | |
| HumanPheno | Focal pedal automatism seizure | 3.04e-05 | 4 | 12 | 2 | HP:0032901 | |
| HumanPheno | Dissociated sensory loss | 3.04e-05 | 4 | 12 | 2 | HP:0010835 | |
| HumanPheno | Focal aware seizure | 3.17e-05 | 28 | 12 | 3 | HP:0002349 | |
| HumanPheno | Abnormal knee physiology | 3.54e-05 | 87 | 12 | 4 | HP:0034670 | |
| HumanPheno | Abnormal facial expression | 3.85e-05 | 185 | 12 | 5 | HP:0005346 | |
| HumanPheno | Hypsarrhythmia | 3.85e-05 | 185 | 12 | 5 | HP:0002521 | |
| HumanPheno | Interictal epileptiform activity | 3.85e-05 | 319 | 12 | 6 | HP:0011182 | |
| HumanPheno | Interictal EEG abnormality | 4.29e-05 | 325 | 12 | 6 | HP:0025373 | |
| HumanPheno | Cogwheel rigidity | 4.77e-05 | 32 | 12 | 3 | HP:0002396 | |
| HumanPheno | Atonic seizure | 4.81e-05 | 94 | 12 | 4 | HP:0010819 | |
| HumanPheno | Seesaw nystagmus | 5.07e-05 | 5 | 12 | 2 | HP:0012044 | |
| HumanPheno | Spontaneous pain sensation | 5.07e-05 | 5 | 12 | 2 | HP:0010833 | |
| HumanPheno | Allodynia | 5.07e-05 | 5 | 12 | 2 | HP:0012533 | |
| HumanPheno | Encephalopathy | 5.09e-05 | 335 | 12 | 6 | HP:0001298 | |
| HumanPheno | Obsessive-compulsive trait | 5.24e-05 | 33 | 12 | 3 | HP:0008770 | |
| HumanPheno | Abnormality of temperature sensation | 5.74e-05 | 34 | 12 | 3 | HP:0100772 | |
| HumanPheno | Impaired temperature sensation | 5.74e-05 | 34 | 12 | 3 | HP:0010829 | |
| HumanPheno | Calcaneovalgus deformity | 5.74e-05 | 34 | 12 | 3 | HP:0001848 | |
| HumanPheno | Abnormality of the autonomic nervous system | 6.12e-05 | 346 | 12 | 6 | HP:0002270 | |
| HumanPheno | Focal-onset seizure | 6.12e-05 | 346 | 12 | 6 | HP:0007359 | |
| HumanPheno | Deformed tarsal bones | 6.27e-05 | 35 | 12 | 3 | HP:0008119 | |
| HumanPheno | Action tremor | 7.10e-05 | 210 | 12 | 5 | HP:0002345 | |
| HumanPheno | Abnormal tibia morphology | 8.00e-05 | 107 | 12 | 4 | HP:0002992 | |
| HumanPheno | Myoclonus | 9.09e-05 | 371 | 12 | 6 | HP:0001336 | |
| HumanPheno | Hyperkinetic movements | 9.40e-05 | 40 | 12 | 3 | HP:0002487 | |
| HumanPheno | Focal non-motor seizure | 9.40e-05 | 40 | 12 | 3 | HP:0032679 | |
| HumanPheno | Abnormality of pain sensation | 9.91e-05 | 113 | 12 | 4 | HP:0010832 | |
| HumanPheno | Generalized-onset motor seizure | 1.05e-04 | 228 | 12 | 5 | HP:0032677 | |
| HumanPheno | Focal clonic seizure | 1.09e-04 | 42 | 12 | 3 | HP:0002266 | |
| HumanPheno | EEG with focal epileptiform discharges | 1.17e-04 | 118 | 12 | 4 | HP:0011185 | |
| HumanPheno | Psychomotor regression | 1.20e-04 | 390 | 12 | 6 | HP:0002489 | |
| HumanPheno | Mental deterioration | 1.20e-04 | 390 | 12 | 6 | HP:0001268 | |
| HumanPheno | Epileptic encephalopathy | 1.21e-04 | 119 | 12 | 4 | HP:0200134 | |
| HumanPheno | Motor seizure | 1.21e-04 | 586 | 12 | 7 | HP:0020219 | |
| HumanPheno | Poor head control | 1.22e-04 | 235 | 12 | 5 | HP:0002421 | |
| HumanPheno | Bilateral tonic-clonic seizure | 1.27e-04 | 394 | 12 | 6 | HP:0002069 | |
| HumanPheno | First dorsal interossei muscle weakness | 1.41e-04 | 8 | 12 | 2 | HP:0003392 | |
| HumanPheno | Chorea | 1.57e-04 | 248 | 12 | 5 | HP:0002072 | |
| HumanPheno | Abnormal hippocampus morphology | 1.63e-04 | 48 | 12 | 3 | HP:0025100 | |
| HumanPheno | Dialeptic seizure | 1.66e-04 | 251 | 12 | 5 | HP:0011146 | |
| HumanPheno | Abnormal morphology of the limbic system | 1.73e-04 | 49 | 12 | 3 | HP:0007343 | |
| HumanPheno | Pallor | 1.75e-04 | 417 | 12 | 6 | HP:0000980 | |
| HumanPheno | Abnormal exteroceptive sensation | 1.93e-04 | 259 | 12 | 5 | HP:0033747 | |
| HumanPheno | Myoclonic seizure | 2.04e-04 | 262 | 12 | 5 | HP:0032794 | |
| HumanPheno | Bilateral tonic-clonic seizure with focal onset | 2.07e-04 | 52 | 12 | 3 | HP:0007334 | |
| HumanPheno | Bilateral tonic-clonic seizure with generalized onset | 2.07e-04 | 52 | 12 | 3 | HP:0025190 | |
| HumanPheno | Gait ataxia | 2.07e-04 | 263 | 12 | 5 | HP:0002066 | |
| HumanPheno | Global brain atrophy | 2.16e-04 | 138 | 12 | 4 | HP:0002283 | |
| HumanPheno | Parkinsonism | 2.16e-04 | 138 | 12 | 4 | HP:0001300 | |
| HumanPheno | EEG with generalized sharp slow waves | 2.27e-04 | 10 | 12 | 2 | HP:0011199 | |
| HumanPheno | Decreased vigilance | 2.27e-04 | 10 | 12 | 2 | HP:0032044 | |
| HumanPheno | Erythromelalgia | 2.27e-04 | 10 | 12 | 2 | HP:0032147 | |
| MousePheno | tonic seizures | 4.66e-08 | 25 | 21 | 4 | MP:0002826 | |
| MousePheno | abnormal action potential | 1.30e-06 | 133 | 21 | 5 | MP:0005402 | |
| MousePheno | convulsive seizures | 2.60e-06 | 153 | 21 | 5 | MP:0000947 | |
| MousePheno | seizures | 1.09e-05 | 360 | 21 | 6 | MP:0002064 | |
| MousePheno | impaired limb coordination | 9.00e-05 | 59 | 21 | 3 | MP:0001524 | |
| MousePheno | abnormal nervous system electrophysiology | 1.05e-04 | 329 | 21 | 5 | MP:0002272 | |
| MousePheno | abnormal brain wave pattern | 1.15e-04 | 64 | 21 | 3 | MP:0004994 | |
| MousePheno | impaired ability to fire action potentials | 1.66e-04 | 13 | 21 | 2 | MP:0002578 | |
| MousePheno | clonic seizures | 1.93e-04 | 14 | 21 | 2 | MP:0003996 | |
| MousePheno | abnormal cerebellar granule layer morphology | 2.67e-04 | 85 | 21 | 3 | MP:0000886 | |
| MousePheno | abnormal brainstem morphology | 3.26e-04 | 227 | 21 | 4 | MP:0005277 | |
| MousePheno | abnormal hippocampus granule cell layer | 4.02e-04 | 20 | 21 | 2 | MP:0008285 | |
| MousePheno | abnormal posture | 4.22e-04 | 243 | 21 | 4 | MP:0001504 | |
| MousePheno | abnormal spike wave discharge | 5.82e-04 | 24 | 21 | 2 | MP:0008840 | |
| MousePheno | abnormal habituation | 5.82e-04 | 24 | 21 | 2 | MP:0011617 | |
| MousePheno | ataxia | 5.94e-04 | 266 | 21 | 4 | MP:0001393 | |
| MousePheno | paralysis | 7.15e-04 | 119 | 21 | 3 | MP:0000753 | |
| MousePheno | abnormal nonassociative learning | 7.38e-04 | 27 | 21 | 2 | MP:0011616 | |
| MousePheno | apnea | 7.38e-04 | 27 | 21 | 2 | MP:0001957 | |
| MousePheno | impaired balance | 7.51e-04 | 121 | 21 | 3 | MP:0001525 | |
| MousePheno | abnormal enzyme/coenzyme activity | 7.90e-04 | 287 | 21 | 4 | MP:0005584 | |
| MousePheno | abnormal tail movements | 8.52e-04 | 29 | 21 | 2 | MP:0001391 | |
| MousePheno | perinatal lethality | 9.36e-04 | 1130 | 21 | 7 | MP:0002081 | |
| MousePheno | abnormal breathing pattern | 9.68e-04 | 303 | 21 | 4 | MP:0001951 | |
| MousePheno | abnormal seizure response to electrical stimulation | 1.04e-03 | 32 | 21 | 2 | MP:0001650 | |
| MousePheno | weight loss | 1.08e-03 | 312 | 21 | 4 | MP:0001263 | |
| MousePheno | abnormal channel response | 1.10e-03 | 33 | 21 | 2 | MP:0003484 | |
| MousePheno | abnormal single cell response | 1.24e-03 | 35 | 21 | 2 | MP:0003463 | |
| MousePheno | absence seizures | 1.24e-03 | 35 | 21 | 2 | MP:0003216 | |
| MousePheno | abnormal mechanical nociception | 1.31e-03 | 36 | 21 | 2 | MP:0002734 | |
| MousePheno | abnormal stationary movement | 1.32e-03 | 147 | 21 | 3 | MP:0001388 | |
| MousePheno | hindlimb paresis | 1.39e-03 | 37 | 21 | 2 | MP:0031204 | |
| MousePheno | abnormal respiratory system physiology | 1.62e-03 | 897 | 21 | 6 | MP:0002133 | |
| MousePheno | abnormal respiration | 1.62e-03 | 598 | 21 | 5 | MP:0001943 | |
| MousePheno | nonconvulsive seizures | 1.62e-03 | 40 | 21 | 2 | MP:0000948 | |
| MousePheno | abnormal RR interval | 1.68e-03 | 160 | 21 | 3 | MP:0010504 | |
| MousePheno | tremors | 1.70e-03 | 353 | 21 | 4 | MP:0000745 | |
| MousePheno | abnormal thermal nociception | 1.93e-03 | 168 | 21 | 3 | MP:0002733 | |
| MousePheno | hypoalgesia | 2.00e-03 | 170 | 21 | 3 | MP:0003043 | |
| MousePheno | abnormal cerebellar granule cell morphology | 2.05e-03 | 45 | 21 | 2 | MP:0004098 | |
| MousePheno | lethality at weaning, complete penetrance | 2.14e-03 | 46 | 21 | 2 | MP:0011083 | |
| MousePheno | abnormal heart electrocardiography waveform feature | 2.17e-03 | 377 | 21 | 4 | MP:0010508 | |
| MousePheno | impaired righting response | 2.35e-03 | 180 | 21 | 3 | MP:0001523 | |
| MousePheno | abnormal response to social novelty | 2.42e-03 | 49 | 21 | 2 | MP:0020395 | |
| MousePheno | abnormal CNS synaptic transmission | 2.61e-03 | 985 | 21 | 6 | MP:0002206 | |
| MousePheno | abnormal respiratory function | 2.66e-03 | 399 | 21 | 4 | MP:0002327 | |
| MousePheno | abnormal impulse conducting system conduction | 2.69e-03 | 400 | 21 | 4 | MP:0003137 | |
| MousePheno | paresis | 2.83e-03 | 53 | 21 | 2 | MP:0000754 | |
| MousePheno | decreased thermal nociceptive threshold | 2.93e-03 | 54 | 21 | 2 | MP:0003998 | |
| MousePheno | abnormal righting response | 2.95e-03 | 195 | 21 | 3 | MP:0002862 | |
| MousePheno | prolonged QT interval | 3.04e-03 | 55 | 21 | 2 | MP:0003233 | |
| MousePheno | abnormal seizure response to inducing agent | 3.22e-03 | 201 | 21 | 3 | MP:0009357 | |
| MousePheno | abnormal postural reflex | 3.31e-03 | 203 | 21 | 3 | MP:0002980 | |
| MousePheno | abnormal Purkinje cell morphology | 3.36e-03 | 204 | 21 | 3 | MP:0000877 | |
| MousePheno | stereotypic behavior | 3.84e-03 | 214 | 21 | 3 | MP:0001408 | |
| MousePheno | abnormal cerebellar molecular layer | 3.85e-03 | 62 | 21 | 2 | MP:0000889 | |
| MousePheno | abnormal noradrenaline level | 3.85e-03 | 62 | 21 | 2 | MP:0003964 | |
| MousePheno | postnatal lethality, complete penetrance | 3.94e-03 | 445 | 21 | 4 | MP:0011085 | |
| MousePheno | abnormal synaptic transmission | 3.96e-03 | 1070 | 21 | 6 | MP:0003635 | |
| MousePheno | abnormal synaptic physiology | 4.07e-03 | 1076 | 21 | 6 | MP:0021009 | |
| MousePheno | abnormal cerebellar Purkinje cell layer | 4.15e-03 | 220 | 21 | 3 | MP:0000875 | |
| MousePheno | decreased kidney weight | 4.35e-03 | 66 | 21 | 2 | MP:0003918 | |
| MousePheno | short stride length | 4.75e-03 | 69 | 21 | 2 | MP:0001407 | |
| Domain | Na_channel_asu | 8.72e-13 | 10 | 26 | 5 | IPR001696 | |
| Domain | Na_trans_assoc | 8.72e-13 | 10 | 26 | 5 | IPR010526 | |
| Domain | Na_trans_assoc | 8.72e-13 | 10 | 26 | 5 | PF06512 | |
| Domain | Na_trans_cytopl | 4.42e-11 | 6 | 26 | 4 | PF11933 | |
| Domain | Na_trans_cytopl | 4.42e-11 | 6 | 26 | 4 | IPR024583 | |
| Domain | Channel_four-helix_dom | 1.35e-10 | 57 | 26 | 6 | IPR027359 | |
| Domain | - | 1.35e-10 | 57 | 26 | 6 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 9.44e-09 | 114 | 26 | 6 | IPR005821 | |
| Domain | Ion_trans | 9.44e-09 | 114 | 26 | 6 | PF00520 | |
| Domain | IQ_motif_EF-hand-BS | 1.41e-07 | 90 | 26 | 5 | IPR000048 | |
| Domain | IQ | 1.66e-07 | 93 | 26 | 5 | PS50096 | |
| Domain | IQ | 2.69e-06 | 71 | 26 | 4 | PF00612 | |
| Domain | IQ | 4.56e-06 | 81 | 26 | 4 | SM00015 | |
| Domain | EF-hand-dom_pair | 7.19e-03 | 287 | 26 | 3 | IPR011992 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.51e-09 | 31 | 24 | 5 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.79e-09 | 32 | 24 | 5 | M27455 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.60e-06 | 121 | 24 | 5 | M872 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.28e-06 | 130 | 24 | 5 | M27454 | |
| Pathway | WP_DRAVET_SYNDROME | 1.38e-05 | 28 | 24 | 3 | M45519 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.00e-05 | 203 | 24 | 5 | M5485 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 6.69e-05 | 47 | 24 | 3 | M42524 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 2.49e-04 | 73 | 24 | 3 | MM16641 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 3.29e-04 | 367 | 24 | 5 | M48346 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 5.52e-04 | 636 | 24 | 6 | M41834 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.14e-15 | 6 | 27 | 5 | 23652591 | |
| Pubmed | 2.39e-14 | 9 | 27 | 5 | 16382098 | ||
| Pubmed | 2.44e-13 | 13 | 27 | 5 | 15123669 | ||
| Pubmed | 1.44e-12 | 5 | 27 | 4 | 8812438 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 19284629 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 12610651 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 33895391 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 23859570 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 19699781 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 14973256 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 18784617 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 17544618 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 17537961 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 35031483 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 29578003 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 35801810 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 22260870 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 1.67e-09 | 4 | 27 | 3 | 8974318 | |
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 1679748 | ||
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 24337656 | ||
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 1.46e-08 | 7 | 27 | 3 | 24440715 | |
| Pubmed | 2.33e-08 | 8 | 27 | 3 | 25101983 | ||
| Pubmed | Genetic mapping of the peripheral sodium channel genes, Scn9a and Scn10a, in the mouse. | 3.49e-08 | 9 | 27 | 3 | 8854872 | |
| Pubmed | 3.49e-08 | 9 | 27 | 3 | 15746173 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 7.13e-08 | 139 | 27 | 5 | 16985003 | |
| Pubmed | 9.14e-08 | 12 | 27 | 3 | 8169823 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 9.14e-08 | 12 | 27 | 3 | 30175250 | |
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 1.89e-07 | 15 | 27 | 3 | 9726281 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 29649454 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 20346423 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26311622 | ||
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 5.80e-07 | 2 | 27 | 2 | 10827969 | |
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 5.80e-07 | 2 | 27 | 2 | 15249644 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27690330 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 19694741 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 5.80e-07 | 2 | 27 | 2 | 11245985 | |
| Pubmed | Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. | 5.80e-07 | 2 | 27 | 2 | 16111501 | |
| Pubmed | Inherited neuronal ion channelopathies: new windows on complex neurological diseases. | 5.80e-07 | 2 | 27 | 2 | 19005038 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 21377452 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 5.80e-07 | 2 | 27 | 2 | 1317301 | |
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 5.80e-07 | 2 | 27 | 2 | 23965409 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 5.80e-07 | 2 | 27 | 2 | 23016767 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27153334 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 33096315 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 5.80e-07 | 2 | 27 | 2 | 24990319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 5.80e-07 | 2 | 27 | 2 | 25172946 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 31439038 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 30693367 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 19270815 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 28784306 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 20301562 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 16052353 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 32185219 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 38999942 | ||
| Pubmed | Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine. | 1.74e-06 | 3 | 27 | 2 | 18056581 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 15314237 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 32005694 | ||
| Pubmed | The cell and molecular basis of mechanical, cold, and inflammatory pain. | 1.74e-06 | 3 | 27 | 2 | 18669863 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 25155934 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 17928448 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 29486580 | ||
| Pubmed | Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. | 1.74e-06 | 3 | 27 | 2 | 30554136 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 22449024 | ||
| Pubmed | Sodium channel Na(v)1.7 is essential for lowering heat pain threshold after burn injury. | 1.74e-06 | 3 | 27 | 2 | 22875917 | |
| Pubmed | Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice. | 1.74e-06 | 3 | 27 | 2 | 17052333 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 32845893 | ||
| Pubmed | FHM3 in familial hemiplegic migraine is more resistant to mutation than FHM1 and FHM2. | 1.74e-06 | 3 | 27 | 2 | 19007941 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 28518218 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 28074005 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 27816501 | ||
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 31980564 | ||
| Pubmed | Nav1.7 as a chondrocyte regulator and therapeutic target for osteoarthritis. | 3.48e-06 | 4 | 27 | 2 | 38172636 | |
| Pubmed | Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. | 3.48e-06 | 4 | 27 | 2 | 26637798 | |
| Pubmed | Nedd4-2 haploinsufficiency causes hyperactivity and increased sensitivity to inflammatory stimuli. | 3.48e-06 | 4 | 27 | 2 | 27604420 | |
| Pubmed | Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons. | 3.48e-06 | 4 | 27 | 2 | 22531176 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 10198179 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 26747084 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 21156207 | ||
| Pubmed | Analgesic targets identified in mouse sensory neuron somata and terminal pain translatomes. | 3.48e-06 | 4 | 27 | 2 | 39163201 | |
| Pubmed | Pain-causing stinging nettle toxins target TMEM233 to modulate NaV1.7 function. | 5.80e-06 | 5 | 27 | 2 | 37117223 | |
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 5.80e-06 | 5 | 27 | 2 | 22875929 | |
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 17724025 | ||
| Pubmed | 8.69e-06 | 6 | 27 | 2 | 16029194 | ||
| Pubmed | 8.69e-06 | 6 | 27 | 2 | 23711479 | ||
| Pubmed | 8.69e-06 | 6 | 27 | 2 | 9143501 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 1.22e-05 | 7 | 27 | 2 | 25818041 | |
| Pubmed | 1.22e-05 | 7 | 27 | 2 | 23575686 | ||
| Pubmed | Report and abstracts of the Fourth International Workshop on Human Chromosome 2 Mapping 1996. | 2.30e-05 | 71 | 27 | 3 | 8751373 | |
| Pubmed | Common variants associated with general and MMR vaccine-related febrile seizures. | 2.60e-05 | 10 | 27 | 2 | 25344690 | |
| Pubmed | 2.60e-05 | 10 | 27 | 2 | 20602612 | ||
| Pubmed | 4.50e-05 | 13 | 27 | 2 | 35904071 | ||
| Pubmed | 8.81e-05 | 18 | 27 | 2 | 11278902 | ||
| Pubmed | 1.21e-04 | 21 | 27 | 2 | 25369838 | ||
| Pubmed | Cerebellar dysfunction and schizophrenia-like behavior in Ebp1-deficient mice. | 1.86e-04 | 26 | 27 | 2 | 35165395 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.96e-04 | 377 | 27 | 4 | 38117590 | |
| Pubmed | 2.57e-04 | 405 | 27 | 4 | 38187761 | ||
| Pubmed | 5.87e-04 | 504 | 27 | 4 | 34432599 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 7.09e-04 | 942 | 27 | 5 | 31073040 | |
| Pubmed | 7.44e-04 | 952 | 27 | 5 | 38569033 | ||
| Interaction | SCN11A interactions | 3.45e-09 | 15 | 27 | 4 | int:SCN11A | |
| Interaction | CACNA1D interactions | 2.66e-08 | 24 | 27 | 4 | int:CACNA1D | |
| Interaction | SCN1A interactions | 5.93e-08 | 29 | 27 | 4 | int:SCN1A | |
| Interaction | SCN10A interactions | 3.51e-07 | 11 | 27 | 3 | int:SCN10A | |
| Interaction | SCN5A interactions | 4.38e-07 | 47 | 27 | 4 | int:SCN5A | |
| Interaction | NALCN interactions | 7.73e-07 | 14 | 27 | 3 | int:NALCN | |
| Interaction | CACNA1C interactions | 1.27e-06 | 61 | 27 | 4 | int:CACNA1C | |
| Interaction | OR2T12 interactions | 1.73e-06 | 2 | 27 | 2 | int:OR2T12 | |
| Interaction | SCN9A interactions | 2.81e-06 | 21 | 27 | 3 | int:SCN9A | |
| Interaction | OR2T33 interactions | 5.18e-06 | 3 | 27 | 2 | int:OR2T33 | |
| Interaction | CACNA1B interactions | 1.62e-05 | 37 | 27 | 3 | int:CACNA1B | |
| Interaction | CACNA1A interactions | 2.08e-05 | 123 | 27 | 4 | int:CACNA1A | |
| Interaction | SCN4B interactions | 4.82e-05 | 8 | 27 | 2 | int:SCN4B | |
| Interaction | NEDD4L interactions | 5.93e-05 | 320 | 27 | 5 | int:NEDD4L | |
| Interaction | RDH8 interactions | 7.73e-05 | 10 | 27 | 2 | int:RDH8 | |
| Interaction | ANK3 interactions | 1.41e-04 | 201 | 27 | 4 | int:ANK3 | |
| Interaction | HRAS interactions | 3.29e-04 | 725 | 27 | 6 | int:HRAS | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 9.33e-07 | 127 | 27 | 4 | chr2q24 | |
| Cytoband | 2q24 | 1.83e-05 | 11 | 27 | 2 | 2q24 | |
| Cytoband | 1q44 | 3.75e-05 | 110 | 27 | 3 | 1q44 | |
| Cytoband | 2q24.3 | 3.98e-05 | 16 | 27 | 2 | 2q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 5.90e-05 | 128 | 27 | 3 | chr1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q24 | 1.84e-02 | 355 | 27 | 2 | chr8q24 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.06e-13 | 9 | 22 | 5 | 1203 | |
| GeneFamily | Olfactory receptors, family 2 | 3.36e-04 | 113 | 22 | 3 | 149 | |
| GeneFamily | Endogenous ligands | 2.85e-03 | 237 | 22 | 3 | 542 | |
| CoexpressionAtlas | BM Top 100 - thalamus | 4.59e-05 | 62 | 24 | 3 | BM Top 100 - thalamus | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.01e-07 | 200 | 26 | 5 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.01e-07 | 200 | 26 | 5 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.01e-07 | 200 | 26 | 5 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.01e-07 | 200 | 26 | 5 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.01e-07 | 200 | 26 | 5 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.01e-07 | 200 | 26 | 5 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.91e-06 | 155 | 26 | 4 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.69e-06 | 169 | 26 | 4 | f077e39e41fffe7672541f5b72b80faaf56c597c | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-06 | 170 | 26 | 4 | 35e3945d8a540a3e2cec1b559316265aaad023d1 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-06 | 170 | 26 | 4 | 0ea625abaa25bab93b70b7000e8f90d5c0f9a0fb | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-06 | 170 | 26 | 4 | 0b5ddc7d452db0a389927a367914f7d257703f7e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-06 | 175 | 26 | 4 | 787ac1a12cda10af5c8830471702a4cbaf43e79e | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.16e-06 | 176 | 26 | 4 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-06 | 179 | 26 | 4 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 4.37e-06 | 191 | 26 | 4 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.04e-06 | 198 | 26 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.04e-06 | 198 | 26 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.04e-06 | 198 | 26 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-05 | 145 | 26 | 3 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.24e-05 | 146 | 26 | 3 | e887e9de895fd453faa703997ef372cc6410fc49 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.10e-05 | 151 | 26 | 3 | f41c6558a5874b6464c157027fdf202257c60e5b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.06e-04 | 159 | 26 | 3 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 161 | 26 | 3 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 161 | 26 | 3 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 161 | 26 | 3 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 162 | 26 | 3 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 164 | 26 | 3 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 164 | 26 | 3 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 164 | 26 | 3 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 164 | 26 | 3 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 165 | 26 | 3 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 165 | 26 | 3 | 1890f9c33b0c5b381d57f97042da2610a093a6de | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 165 | 26 | 3 | 507c89ece0a336b8e9c65b79889a714e17ddca27 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 165 | 26 | 3 | 39a25be081a5d59c7cf107a997d352793d5025fb | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 1.23e-04 | 167 | 26 | 3 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.25e-04 | 168 | 26 | 3 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 1.27e-04 | 169 | 26 | 3 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-04 | 170 | 26 | 3 | 02f0be0aab8ba2d35a83238609352ef3677511c9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 172 | 26 | 3 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 172 | 26 | 3 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 173 | 26 | 3 | 07798461d12d04f3dabff03481c999cb07c5af2f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 174 | 26 | 3 | a62531ebf16b32b249168dca11b870f63a8aa81c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 175 | 26 | 3 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 176 | 26 | 3 | fb718a6b07aa5d56600263280afa530bcb63db42 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 177 | 26 | 3 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | ASK454-Endothelial-Lymphatic|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.51e-04 | 179 | 26 | 3 | fd84a79f76a01c0377dff5b20016b004d369f96f | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.51e-04 | 179 | 26 | 3 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 180 | 26 | 3 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Pulmonary_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.53e-04 | 180 | 26 | 3 | 57689ccbbd44c0e78e061edd87d3102c5f2dcc9a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 180 | 26 | 3 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Macrophage|bone_marrow / Manually curated celltypes from each tissue | 1.56e-04 | 181 | 26 | 3 | d2aa5b53162fb5c4cbbedbd2cb4b2b614e8c4afa | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 1.58e-04 | 182 | 26 | 3 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 182 | 26 | 3 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.61e-04 | 183 | 26 | 3 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 183 | 26 | 3 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 184 | 26 | 3 | 9690d4290e70f9bda889754ffb30b0af1f7cb94b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 184 | 26 | 3 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 185 | 26 | 3 | 2a8104f610fa5ce618f8105521616722462a0d42 | |
| ToppCell | 18-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 1.66e-04 | 185 | 26 | 3 | f8fc7b12b4e18d23d84e95488be93c4352d325f3 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 185 | 26 | 3 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 186 | 26 | 3 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.69e-04 | 186 | 26 | 3 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.69e-04 | 186 | 26 | 3 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | facs-Heart-LA-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 187 | 26 | 3 | b0768a0102d533bc6c9efe56b7a9c18db7a374b7 | |
| ToppCell | facs-Heart-LA-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 187 | 26 | 3 | 87d4323a72e96ce35f9981faa92ded846a474384 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 187 | 26 | 3 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 188 | 26 | 3 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 188 | 26 | 3 | 1f912ea015f50570e848259d948a0ba682d64bb4 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.74e-04 | 188 | 26 | 3 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.74e-04 | 188 | 26 | 3 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.74e-04 | 188 | 26 | 3 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 188 | 26 | 3 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | 21-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 1.74e-04 | 188 | 26 | 3 | e78d4f7a5d28c77503cb041ff585d13df4c88bd2 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.74e-04 | 188 | 26 | 3 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 189 | 26 | 3 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 189 | 26 | 3 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.77e-04 | 189 | 26 | 3 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 189 | 26 | 3 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-04 | 190 | 26 | 3 | 40d8b3403f4e38436b961cd3a2e69826cbae3042 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-04 | 190 | 26 | 3 | f6cbf6d292f488ada5f7581e1dceba6198b933d1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.79e-04 | 190 | 26 | 3 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-04 | 190 | 26 | 3 | a9a705455019e28d655636de73b07540798f82e6 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-04 | 192 | 26 | 3 | 5f4f44f15d3a2846981e68296643a4634930a211 | |
| ToppCell | facs-Heart-LA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 192 | 26 | 3 | 5238506f2bb8bd36a49d3012442f45063c0550e6 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-04 | 192 | 26 | 3 | 5e709c0714e8eba27e03a6def0544256bedb3ced | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.85e-04 | 192 | 26 | 3 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 193 | 26 | 3 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 193 | 26 | 3 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 193 | 26 | 3 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 193 | 26 | 3 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-F_(Lymphatics)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.91e-04 | 194 | 26 | 3 | 9441202d6fa2ffbef9277d48ae9bc98876c26ec5 | |
| ToppCell | distal-2-Endothelial-Lymphatic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-04 | 195 | 26 | 3 | 8e0f67a67af3bc0b16f48a621f74540f136383b7 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.94e-04 | 195 | 26 | 3 | fc75f04eb475c8139cc5c35e6be22e73fb2be9e6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.94e-04 | 195 | 26 | 3 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.94e-04 | 195 | 26 | 3 | 83d45ff5e5bc704448431149fffb2e4c1278f279 | |
| ToppCell | distal-Endothelial-Lymphatic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-04 | 195 | 26 | 3 | f45c1349932ee7eb419cced8a4fdedae3610953f | |
| ToppCell | (08)_PNEC|World / shred by cell type and Timepoint | 1.97e-04 | 196 | 26 | 3 | 2ee37155c03cd5009427a4bffe6c80ed2ac6939e | |
| ToppCell | distal-Endothelial-Lymphatic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.97e-04 | 196 | 26 | 3 | 3e8a20e1d163dcbd3bbd99fe179d54af02298af0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.97e-04 | 196 | 26 | 3 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| Drug | Zonisamide | 2.66e-09 | 17 | 25 | 4 | DB00909 | |
| Drug | APETx1, Anthopleura elegantissima | 2.33e-08 | 6 | 25 | 3 | ctd:C475726 | |
| Drug | fenpropathrin | 2.33e-08 | 6 | 25 | 3 | ctd:C044267 | |
| Drug | NSC7524 | 3.75e-08 | 182 | 25 | 6 | CID000005657 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 6.52e-08 | 8 | 25 | 3 | ctd:C489827 | |
| Drug | benzocaine | 7.28e-08 | 37 | 25 | 4 | CID000002337 | |
| Drug | Tetrodotoxin | 1.01e-07 | 40 | 25 | 4 | ctd:D013779 | |
| Drug | phenytoin | 1.12e-07 | 219 | 25 | 6 | CID000001775 | |
| Drug | lamotrigine | 1.54e-07 | 116 | 25 | 5 | CID000003878 | |
| Drug | saxitoxin | 7.31e-07 | 65 | 25 | 4 | CID000037165 | |
| Drug | GBR 12909 | 9.31e-07 | 69 | 25 | 4 | CID000003455 | |
| Drug | Scorpion Venoms | 9.44e-07 | 18 | 25 | 3 | ctd:D012604 | |
| Drug | gabapentin | 1.00e-06 | 169 | 25 | 5 | CID000003446 | |
| Drug | diprafenone | 1.12e-06 | 19 | 25 | 3 | CID000071249 | |
| Drug | diphenhydramine | 1.30e-06 | 75 | 25 | 4 | CID000003100 | |
| Drug | Sodium | 2.06e-06 | 84 | 25 | 4 | ctd:D012964 | |
| Drug | AC1Q6NIK | 2.33e-06 | 24 | 25 | 3 | CID000065939 | |
| Drug | AC1NT1AF | 2.65e-06 | 25 | 25 | 3 | CID005322157 | |
| Drug | Pirmenolum | 2.99e-06 | 26 | 25 | 3 | CID000004853 | |
| Drug | AC1L1MOZ | 3.36e-06 | 27 | 25 | 3 | CID000031958 | |
| Drug | nefopam | 3.36e-06 | 27 | 25 | 3 | CID000004450 | |
| Drug | PbTx-1 | 3.36e-06 | 27 | 25 | 3 | CID006437089 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 3.47e-06 | 3 | 25 | 2 | ctd:C561228 | |
| Drug | paraben | 3.76e-06 | 28 | 25 | 3 | CID000007175 | |
| Drug | pentobarbital | 3.99e-06 | 224 | 25 | 5 | CID000004737 | |
| Drug | isradipine | 4.13e-06 | 100 | 25 | 4 | CID000003784 | |
| Drug | cyfluthrin | 4.19e-06 | 29 | 25 | 3 | ctd:C052570 | |
| Drug | tocainide | 4.66e-06 | 30 | 25 | 3 | CID000038945 | |
| Drug | sodium | 4.89e-06 | 944 | 25 | 8 | CID000000923 | |
| Drug | tetradotoxin | 5.57e-06 | 428 | 25 | 6 | CID000020382 | |
| Drug | NSC93767 | 5.68e-06 | 32 | 25 | 3 | CID000005658 | |
| Drug | 5-hydroxypropafenone | 6.84e-06 | 34 | 25 | 3 | CID000107927 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 6.94e-06 | 4 | 25 | 2 | ctd:C501880 | |
| Drug | Lidocaine | 6.94e-06 | 4 | 25 | 2 | DB00281 | |
| Drug | hydrochlorothiazide | 8.52e-06 | 120 | 25 | 4 | CID000003639 | |
| Drug | aprindine | 9.62e-06 | 38 | 25 | 3 | CID000002218 | |
| Drug | bepridil | 1.03e-05 | 126 | 25 | 4 | CID000002351 | |
| Drug | triphosphoinositide | 1.04e-05 | 273 | 25 | 5 | CID009543520 | |
| Drug | S-ropivacaine | 1.12e-05 | 40 | 25 | 3 | CID000071273 | |
| Drug | isoprodian | 1.16e-05 | 5 | 25 | 2 | CID003037188 | |
| Drug | Y11038 | 1.16e-05 | 5 | 25 | 2 | CID000012765 | |
| Drug | clenbuterol | 1.66e-05 | 142 | 25 | 4 | CID000002783 | |
| Drug | pilsicainide | 1.72e-05 | 46 | 25 | 3 | CID000004820 | |
| Drug | spiradoline | 1.72e-05 | 46 | 25 | 3 | CID000005620 | |
| Drug | RSR13 | 1.84e-05 | 47 | 25 | 3 | CID000122335 | |
| Drug | decamethrin | 1.85e-05 | 146 | 25 | 4 | ctd:C017180 | |
| Drug | indoxacarb | 2.08e-05 | 49 | 25 | 3 | CID000107720 | |
| Drug | procaine | 2.22e-05 | 153 | 25 | 4 | CID000004914 | |
| Drug | sodiosodium | 2.80e-05 | 54 | 25 | 3 | CID000141233 | |
| Drug | AC1NSN3X | 2.80e-05 | 54 | 25 | 3 | CID005366189 | |
| Drug | L-threonine amide | 3.23e-05 | 8 | 25 | 2 | CID000444078 | |
| Drug | BT-PABA | 3.29e-05 | 57 | 25 | 3 | CID000002329 | |
| Drug | triamterene | 3.47e-05 | 58 | 25 | 3 | CID000005546 | |
| Drug | riluzole | 3.68e-05 | 174 | 25 | 4 | CID000005070 | |
| Drug | fenfluramine | 4.02e-05 | 178 | 25 | 4 | CID000003337 | |
| Drug | carbamazepine | 4.11e-05 | 179 | 25 | 4 | CID000002554 | |
| Drug | Mexiletine | 4.15e-05 | 9 | 25 | 2 | ctd:D008801 | |
| Drug | zonisamide | 4.24e-05 | 62 | 25 | 3 | CID000005734 | |
| Drug | AC1L1CQC | 4.88e-05 | 65 | 25 | 3 | CID000002012 | |
| Drug | mexiletine | 5.11e-05 | 66 | 25 | 3 | CID000004178 | |
| Drug | resiniferatoxin | 5.11e-05 | 66 | 25 | 3 | CID000104826 | |
| Drug | disopyramide | 5.11e-05 | 66 | 25 | 3 | CID000003114 | |
| Drug | propofol | 5.29e-05 | 191 | 25 | 4 | CID000004943 | |
| Drug | Phenytoin | 5.42e-05 | 385 | 25 | 5 | ctd:D010672 | |
| Drug | dibucaine | 5.59e-05 | 68 | 25 | 3 | CID000003025 | |
| Drug | Bezafibrate [41859-67-0]; Up 200; 11uM; PC3; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 6653_UP | |
| Drug | T2755 | 6.36e-05 | 71 | 25 | 3 | CID000005514 | |
| Drug | flecainide | 6.36e-05 | 71 | 25 | 3 | CID000003355 | |
| Drug | imide | 7.20e-05 | 74 | 25 | 3 | CID000443040 | |
| Drug | 1, 3-diallylurea | 7.20e-05 | 74 | 25 | 3 | CID000074537 | |
| Drug | sorbitan | 7.59e-05 | 12 | 25 | 2 | CID000103023 | |
| Drug | Tetracaine | 7.59e-05 | 12 | 25 | 2 | ctd:D013748 | |
| Drug | potassium | 7.78e-05 | 1008 | 25 | 7 | CID000000813 | |
| Drug | 2N3NAD | 8.96e-05 | 13 | 25 | 2 | CID000164223 | |
| Drug | bupropion | 9.43e-05 | 81 | 25 | 3 | CID000000444 | |
| Drug | carisbamate | 1.38e-04 | 16 | 25 | 2 | CID006918474 | |
| Drug | PD 150606 | 1.56e-04 | 17 | 25 | 2 | ctd:C100442 | |
| Drug | fenvalerate | 1.61e-04 | 97 | 25 | 3 | ctd:C017690 | |
| Drug | propafenone | 1.66e-04 | 98 | 25 | 3 | CID000004932 | |
| Drug | verapamil | 1.68e-04 | 490 | 25 | 5 | CID000002520 | |
| Drug | trimethoprim | 1.71e-04 | 99 | 25 | 3 | CID000005578 | |
| Drug | ketamine | 1.79e-04 | 262 | 25 | 4 | CID000003821 | |
| Drug | hexafluorobenzene | 1.96e-04 | 19 | 25 | 2 | CID000009805 | |
| Drug | AC1NRC8M | 1.96e-04 | 19 | 25 | 2 | CID005288877 | |
| Drug | N-acetyl-L-aspartate | 2.04e-04 | 105 | 25 | 3 | CID000065065 | |
| Drug | pyraclofos | 2.09e-04 | 106 | 25 | 3 | CID000093460 | |
| Drug | AC1O5FLX | 2.17e-04 | 20 | 25 | 2 | CID006433117 | |
| Drug | Nicorette | 2.40e-04 | 529 | 25 | 5 | CID000000942 | |
| Drug | 3-iodo-4-hydroxybenzoic acid | 2.64e-04 | 22 | 25 | 2 | CID000449473 | |
| Drug | PL 0 | 3.15e-04 | 24 | 25 | 2 | CID000016157 | |
| Drug | AC1L2IZE | 3.15e-04 | 24 | 25 | 2 | CID000072928 | |
| Drug | avanafil | 3.15e-04 | 24 | 25 | 2 | CID009869929 | |
| Drug | bupivacaine | 3.40e-04 | 125 | 25 | 3 | CID000002474 | |
| Drug | Multicide | 3.42e-04 | 25 | 25 | 2 | CID000024365 | |
| Drug | conivaptan | 3.42e-04 | 25 | 25 | 2 | CID000151171 | |
| Drug | talnetant | 3.42e-04 | 25 | 25 | 2 | CID000133090 | |
| Drug | Caspofungin [inn] | 4.00e-04 | 27 | 25 | 2 | CID000151068 | |
| Drug | GTP[S] | 4.00e-04 | 591 | 25 | 5 | CID000001764 | |
| Drug | 2MbisP | 4.30e-04 | 28 | 25 | 2 | CID005289547 | |
| Drug | CAAC | 4.61e-04 | 29 | 25 | 2 | CID006436397 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 7.17e-14 | 10 | 25 | 5 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 7.17e-14 | 10 | 25 | 5 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.25e-13 | 12 | 25 | 5 | DOID:0060170 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.90e-09 | 22 | 25 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 4.21e-09 | 163 | 25 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 4.50e-08 | 9 | 25 | 3 | C3502809 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.53e-07 | 13 | 25 | 3 | C0751122 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 6.89e-07 | 2 | 25 | 2 | C4551549 | |
| Disease | Familial or sporadic hemiplegic migraine | 2.07e-06 | 3 | 25 | 2 | cv:CN295307 | |
| Disease | Familial hemiplegic migraine | 2.07e-06 | 3 | 25 | 2 | cv:C0338484 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 2.07e-06 | 3 | 25 | 2 | C1833661 | |
| Disease | Primary Erythermalgia | 2.07e-06 | 3 | 25 | 2 | C0014805 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.44e-05 | 7 | 25 | 2 | C0020075 | |
| Disease | Seizure, Febrile, Simple | 1.44e-05 | 7 | 25 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 1.44e-05 | 7 | 25 | 2 | C0751057 | |
| Disease | Congenital Pain Insensitivity | 1.44e-05 | 7 | 25 | 2 | C0002768 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 1.92e-05 | 8 | 25 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 1.92e-05 | 8 | 25 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 1.92e-05 | 8 | 25 | 2 | C0338479 | |
| Disease | Myoclonic Encephalopathy | 1.92e-05 | 8 | 25 | 2 | C0438414 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 1.92e-05 | 8 | 25 | 2 | C0751120 | |
| Disease | Myoclonic Absence Epilepsy | 1.92e-05 | 8 | 25 | 2 | C0393703 | |
| Disease | Febrile Convulsions | 2.47e-05 | 9 | 25 | 2 | C0009952 | |
| Disease | Myoclonic Epilepsy | 2.47e-05 | 9 | 25 | 2 | C0014550 | |
| Disease | Epilepsy, Myoclonic, Infantile | 3.09e-05 | 10 | 25 | 2 | C0917800 | |
| Disease | Myoclonic Astatic Epilepsy | 3.77e-05 | 11 | 25 | 2 | C0393702 | |
| Disease | MMR-related febrile seizures | 7.19e-05 | 15 | 25 | 2 | EFO_0006519 | |
| Disease | Neuralgia, Supraorbital | 8.21e-05 | 16 | 25 | 2 | C0038870 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 8.21e-05 | 16 | 25 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 8.21e-05 | 16 | 25 | 2 | C0423711 | |
| Disease | Tremor, Rubral | 8.21e-05 | 16 | 25 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 8.21e-05 | 16 | 25 | 2 | C0750937 | |
| Disease | Neuralgia | 8.21e-05 | 16 | 25 | 2 | C0027796 | |
| Disease | Ataxia, Motor | 8.21e-05 | 16 | 25 | 2 | C0278161 | |
| Disease | Abnormal coordination | 8.21e-05 | 16 | 25 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 8.21e-05 | 16 | 25 | 2 | C0427190 | |
| Disease | Neuralgia, Atypical | 8.21e-05 | 16 | 25 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 8.21e-05 | 16 | 25 | 2 | C0234249 | |
| Disease | Paroxysmal Nerve Pain | 8.21e-05 | 16 | 25 | 2 | C0751373 | |
| Disease | Nerve Pain | 8.21e-05 | 16 | 25 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 8.21e-05 | 16 | 25 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 8.21e-05 | 16 | 25 | 2 | C0042656 | |
| Disease | Ataxia, Sensory | 8.21e-05 | 16 | 25 | 2 | C0240991 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 8.21e-05 | 16 | 25 | 2 | C0393706 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.05e-04 | 18 | 25 | 2 | HP_0002373 | |
| Disease | Epilepsy | 1.06e-04 | 109 | 25 | 3 | C0014544 | |
| Disease | Ataxia | 2.04e-04 | 25 | 25 | 2 | C0004134 | |
| Disease | Anemia | 3.80e-04 | 34 | 25 | 2 | C0002871 | |
| Disease | heart failure | 5.04e-04 | 185 | 25 | 3 | EFO_0003144 | |
| Disease | Inherited neuropathies | 5.27e-04 | 40 | 25 | 2 | C0598589 | |
| Disease | QRS complex, QRS duration | 6.67e-04 | 45 | 25 | 2 | EFO_0005054, EFO_0005055 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IMAMIALNTIVLMMK | 1571 | O00555 | |
| MRMMARICLNKEMPP | 331 | Q8WUY9 | |
| KMLMMMALLVPLVYT | 291 | P08574 | |
| CIPVMGLMIYMMVMD | 661 | Q04656 | |
| LMDMMLVSTTVPKMA | 66 | Q8NG77 | |
| MDMQLLMIPLIMSVL | 116 | Q9BUN8 | |
| LMDMMLVSTTVPKMA | 66 | Q8NG76 | |
| MSVMKPCLMTIAILM | 1 | Q30KQ4 | |
| MMAGMKIQLVCMLLL | 1 | P30990 | |
| KLMTPIECAMTMMSH | 636 | Q9P2D3 | |
| DIIVLAKQMCMIMME | 711 | P35221 | |
| QTMLCPEMKIKLAMM | 226 | Q8TAL5 | |
| TVRLILKCSMMPMQV | 506 | P52429 | |
| YPIRMSKMMCVKMIG | 131 | Q8N349 | |
| FAMPMQDIKMILKMV | 216 | P78395 | |
| IMVLICLNMVTMMVE | 1521 | Q15858 | |
| MCAYLKLLPMFLMVM | 316 | Q9NY91 | |
| VMMENKPMTLKLIMT | 146 | Q8WTV0 | |
| IIRTCLGPKSMMKML | 36 | P49368 | |
| SIMILICLNMVTMMV | 1531 | Q9NY46 | |
| MSPAMLSVLVKMMLA | 271 | Q8IUC4 | |
| SIMILICLNMVTMMV | 1546 | P35498 | |
| TIMVLICLNMITMMV | 1481 | Q9Y5Y9 | |
| SIMILICLNMVTMMV | 1536 | Q99250 | |
| MSPAMLSVLVKMMLT | 186 | A8MT19 | |
| IAIQMMMHMQPKEIC | 251 | P07602 | |
| MIPAKDMAKVMIVML | 1 | P01270 |